re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma

Although radiation therapy is the primary treatment for nasopharyngeal carcinoma, radioresistance remains a major obstacle to successful treatment in many cases, and the exact underlying molecular mechanisms are still ill-defined. EMP2 , epithelial membrane protein-2, was a recently identified poten...

Full description

Saved in:
Bibliographic Details
Main Authors: Mei Tang, Ru-yan Liu, Cong Zhou, Meng-zhen Yuan, Dong-ming Wu, Zhu Yuan, Peng Zhang, Jin-yi Lang
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317695972
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850093303910891520
author Mei Tang
Ru-yan Liu
Cong Zhou
Meng-zhen Yuan
Dong-ming Wu
Zhu Yuan
Peng Zhang
Jin-yi Lang
author_facet Mei Tang
Ru-yan Liu
Cong Zhou
Meng-zhen Yuan
Dong-ming Wu
Zhu Yuan
Peng Zhang
Jin-yi Lang
author_sort Mei Tang
collection DOAJ
description Although radiation therapy is the primary treatment for nasopharyngeal carcinoma, radioresistance remains a major obstacle to successful treatment in many cases, and the exact underlying molecular mechanisms are still ill-defined. EMP2 , epithelial membrane protein-2, was a recently identified potential oncogene involved in multiple biological processes including cell migration and cell proliferation. This study was to explore the potential relationship between EMP2 expression, nasopharyngeal carcinoma genesis, and radioresistance. EMP2 expression status in 98 nasopharyngeal carcinoma clinical samples was examined by immunohistochemical staining. As a result, most of the nasopharyngeal carcinoma tumor samples were weakly or negatively stained, while paired adjacent normal tissues were moderately or strongly stained. Moreover, patients with higher expression of EMP2 had significant longer survival times. EMP2 re-expression suppresses cell growth, induces S-phase cell cycle arrest, and promotes radiosensitivity and apoptosis in nasopharyngeal carcinoma cells. These results support that loss of EMP2 is common, and its re-expression may serve as an approach to enhance radiation sensitivity in nasopharyngeal carcinoma.
format Article
id doaj-art-21c8f447e4d44cf8a7c8b1c3c2afb929
institution DOAJ
issn 1423-0380
language English
publishDate 2017-03-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-21c8f447e4d44cf8a7c8b1c3c2afb9292025-08-20T02:41:57ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317695972re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinomaMei Tang0Ru-yan Liu1Cong Zhou2Meng-zhen Yuan3Dong-ming Wu4Zhu Yuan5Peng Zhang6Jin-yi Lang7Laboratory of Tumor Biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, ChinaDepartment of oncology, FuLing Central Hospital, Chongqing, ChinaLaboratory of Tumor Biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, ChinaDepartment of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, ChinaLaboratory of Tumor Biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, ChinaLaboratory of Tumor Biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, ChinaDepartment of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, ChinaDepartment of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, ChinaAlthough radiation therapy is the primary treatment for nasopharyngeal carcinoma, radioresistance remains a major obstacle to successful treatment in many cases, and the exact underlying molecular mechanisms are still ill-defined. EMP2 , epithelial membrane protein-2, was a recently identified potential oncogene involved in multiple biological processes including cell migration and cell proliferation. This study was to explore the potential relationship between EMP2 expression, nasopharyngeal carcinoma genesis, and radioresistance. EMP2 expression status in 98 nasopharyngeal carcinoma clinical samples was examined by immunohistochemical staining. As a result, most of the nasopharyngeal carcinoma tumor samples were weakly or negatively stained, while paired adjacent normal tissues were moderately or strongly stained. Moreover, patients with higher expression of EMP2 had significant longer survival times. EMP2 re-expression suppresses cell growth, induces S-phase cell cycle arrest, and promotes radiosensitivity and apoptosis in nasopharyngeal carcinoma cells. These results support that loss of EMP2 is common, and its re-expression may serve as an approach to enhance radiation sensitivity in nasopharyngeal carcinoma.https://doi.org/10.1177/1010428317695972
spellingShingle Mei Tang
Ru-yan Liu
Cong Zhou
Meng-zhen Yuan
Dong-ming Wu
Zhu Yuan
Peng Zhang
Jin-yi Lang
re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
Tumor Biology
title re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
title_full re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
title_fullStr re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
title_full_unstemmed re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
title_short re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
title_sort re expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma
url https://doi.org/10.1177/1010428317695972
work_keys_str_mv AT meitang reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT ruyanliu reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT congzhou reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT mengzhenyuan reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT dongmingwu reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT zhuyuan reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT pengzhang reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma
AT jinyilang reexpressioninhibitsgrowthandenhancesradiosensitivityinnasopharyngealcarcinoma